re.Mind Capital

re.Mind Capital is a venture capital fund dedicated to investing in radical new ideas to improve mental and neurological health. As the mental health arm of Apeiron Investment Group, founded by Christian Angermayer, re.Mind Capital focuses on supporting visionary founders addressing humanity's most pressing challenges in mental health and neuroscience. The fund invests in companies at various stages, from seed to growth, with a particular emphasis on private equity and venture capital opportunities. Geographically, re.Mind Capital has a diverse focus, including Germany, the United States, the United Kingdom, Malta, Luxembourg, and Abu Dhabi. The fund's investment strategy spans multiple industries, such as mental health, neuroscience, biotech, fintech, deep tech, experiences, hospitality, sports, real estate, and natural resources. Investment sizes typically range from $1 million to $50 million, aligning with re.Mind Capital's commitment to fostering innovation and supporting the development of transformative solutions in the mental health sector.